Buzzes and controversies of last year in the AD literature Dear Colleagues, Dear Friends, On behalf of ISAD, I extend my best wishes for a bright and successful New Year, filled with new achievements that will benefit our patients. We are actively planning our 2025 meetings and are excited to share some updates. Our Spring […]
Read More
Better spatial tissue imaging techniques to differentiate CTCL and AD➜ DOI: 10.1038/s41540-024-00474-xCutaneous T-cell lymphomas (CTCLs) can be difficult to distinguish from inflammatory skin conditions like atopic dermatitis (AD). Multi-antigen imaging protein abundance maps were analyzed with spatial graphs inferred from the cells' positions in the tissue samples. Characteristic patterns of skin tissue organization allowed a high-precision [...] Read More
ATOPIC DERMATITIS with focus on Sub-Saharan Africa Training for national and district-level health workers We are happy to inform you that the 6-module training course on AD including videos is now available on OpenWHO in Spanish!
Read More
AD evidence-based medicine outcome instruments: how to better integrate patients’ preferences? Dear Colleagues, Dear Friends, A recently published study funded by Galderma investigates with the quantitative method named discrete choice experiment (DCE) the preference of patients and physicians when prescribing systemic treatments for AD. This DCE method is increasingly used in healthcare to elicit preferences […]
Read More
Fecal microbiota transplantation (FMT): first RCT.➜ DOI: 10.1111/all.16372This Chinese randomized, double-blind, placebo-controlled clinical trial, studied the efficacy and safety assessment of FMT for moderate-to-severe adult patients with AD. All patients received FMT or placebo as capsules sourced for FMT verum from 2 strictly screened healthy donors once a week for 3 weeks, in addition to their [...] Read More
Asia Pacific Academy of Pediatric Allergy, Respirology & Immunology November 23, 2024, Shenzhen, China The recent APAPARI (Asia Pacific Allergy Academy of Pediatric Allergology) annual congress was held in Shenzhen, China. The ISAD sent a delegation to meet the pediatric colleagues of this region who are caring for a sizable part of the patients worldwide. […]
Read More
ATOPIC DERMATITIS with focus on Sub-Saharan Africa Training for national and district-level health workers This 6-module training course including videos is now available in English and French on the OpenWHO platform. We are happy to inform you that the French course Atopic Dermatitis is now available on OpenWHO.
Read More
#rajka2024doha The 14th Georg RAJKA International Symposium on Atopic Dermatitis attracted over 500 in-person attendees in Doha, along with 150+ online participants, marking it as our largest event to date. At a Glance:
Read More
ISAD plans a celebration of the Centennial birthday anniversary of Georg RAJKA (1925-2013) next year in Melbourne, Australia Dear Colleagues, Dear Friends, Fleeing Hungary, his native country, after the Soviet occupation, Georg RAJKA made in Sweden then Norway an outstanding and very original academic career centered on Prurigo Besnier/AD. Prurigo Besnier was indeed the name […]
Read More
Conjunctival transcriptomic profile predicts dupilumab ocular adverse events➜ DOI: 10.1016/j.jid.2024.08.024DNA microarray analysis was used to compare the transcriptome of AD patients’ conjunctival cells collected before and 4 months after initiating dupilumab treatment. Interestingly, patients developing ocular adverse effects had both before and after treatment a similar transcriptome signature, characterized by the over-expression of several genes involved [...] Read More